52
Genomics for the Child Neurologist: Genetic Testing Process

Session Three: Genetic Testing Process

  • Upload
    nchpeg

  • View
    306

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Session Three: Genetic Testing Process

Genomics for the Child Neurologist:

Genetic Testing Process

Page 2: Session Three: Genetic Testing Process

Facilitator(s)

Name• Expertise• Credentials

• Titles

Page 3: Session Three: Genetic Testing Process

Re-Cap: Evaluation & Testing Decisions

Narrow the differential

Select appropriate tests

Develop a family testing strategy

Page 4: Session Three: Genetic Testing Process

Workshop Three:Genetic Testing Process

Page 5: Session Three: Genetic Testing Process

Identify benefits, limitations, risks

Provide informed consent

Order testing appropriately

Take time to prepare for outcomes of testing

Page 6: Session Three: Genetic Testing Process

Evaluation & Testing DecisionsLearning Objectives

1. Use data to identify limitations of genetic testing

2. Weigh the benefits and risks of testing in the patient’s individual scenario

3. Provide pre-test education and counseling

4. Develop a protocol for ordering appropriate testing

Page 7: Session Three: Genetic Testing Process

2 yo male

History of febrile and afebrile seizures

Clinical Scenario: James

Page 8: Session Three: Genetic Testing Process

James2 y

Seizures

Key

Seizures

SeizuresD. 10

accident

James Family History

Page 9: Session Three: Genetic Testing Process

Evaluations and unique features point toward Dravet syndrome

Differential Diagnosis includes:

•Severe myoclonic epilepsy of infancy (SMEI, or Dravet syndrome)•Pyridoxine, B6 and Folic acid related seizures•Biotinidase deficiency

•Autosomal dominant nocturnal frontal lobe epilepsy

•Simple febrile seizures

Page 10: Session Three: Genetic Testing Process

Overview Dravet Syndrome

Features:•Severe myoclonic epilepsy of infancy•Cognitive decline over time

Genetics: •30-80% cases associated with a variant in SCN1A gene

Inheritance: •Typically de novo (depends on phenotype)•When inherited, autosomal dominant with significant intra-familial variable expression

Management: •Difficult to control•Anticonvulsant drugs and ketogenic diet may reduce seizure frequency

Page 11: Session Three: Genetic Testing Process

Identify benefits, limitations, risks

Page 12: Session Three: Genetic Testing Process

Step 1: Assess ability of the test to detect variants in your patient’s population

What is the yield of genetic testing in a child with severe myoclonic epilepsy?

Page 13: Session Three: Genetic Testing Process

30-80% of individuals with Dravet have a detectable mutation in SCN1A

SCN1A

Other, unknown

genes

Page 14: Session Three: Genetic Testing Process

Step 2: Assess the ability of a variant to predict outcomes

What could the detection of a variant tell the clinician about future outcomes for the patient and risk for family members?

Page 15: Session Three: Genetic Testing Process

Variable expression limits prognostic value and family risk counseling

Page 16: Session Three: Genetic Testing Process

Step 3: Anticipate other results

How would you use a negative result?

What would you do with a variant of uncertain significance?

Page 17: Session Three: Genetic Testing Process

Negative genetic test doesn’t rule out disease in a symptomatic individual

SCN1A

Other, unknown

genes

SCN1APortion of variants

missed by test•Technology limitations•Test selected

No variants detected

Not tested

Page 18: Session Three: Genetic Testing Process

Step 3: Anticipate other results

How would you use a negative result?

What would you do with a variant of uncertain significance?

Page 19: Session Three: Genetic Testing Process

A VUS is uninformative and shouldn’t be used clinically

Not seen in any previous patient

OR

Contradictory reports in other individuals

AND/OR

Unknown effect on gene function

Page 20: Session Three: Genetic Testing Process

Step 4: Identify and weigh risks

What are the general risks associated with genetic testing, and which ones apply to James?

Page 21: Session Three: Genetic Testing Process

General risks of genetic testing

• Discrimination

• Family impact and privacy• Psychosocial coping and adaptation

Page 22: Session Three: Genetic Testing Process

Genetics Information Non-discrimination Act

(GINA) affords some protections

Page 23: Session Three: Genetic Testing Process

How would you discuss the risks, benefits, and limitations of testing?

Page 24: Session Three: Genetic Testing Process

Balance benefits, limitations, and risks in the context of the patient and family

Benefits• End diagnostic odyssey• Clarify reproductive risk• Refine differential

Limitations• Variable expression limits predictions• Uninformative negative• Uninformative VUS

Risks • Clinical uncertainty• Psychosocial impact

Page 25: Session Three: Genetic Testing Process

Summary: Steps To Assessing Limitations and Risks

Step 1: Assess likelihood of detecting a variant

Step 2: Assess ability of a variant to predict outcomes

Step 3: Anticipate other results

Step 4: Identify benefits and risks

Page 26: Session Three: Genetic Testing Process

Provide Informed Consent

Page 27: Session Three: Genetic Testing Process

What do you do for pre-test counseling currently?

Page 28: Session Three: Genetic Testing Process

Informed consent paves the way for results disclosure

Page 29: Session Three: Genetic Testing Process

Small Group Practice

Page 30: Session Three: Genetic Testing Process

7 yo female

Developmental delayHypotoniaDysmorphic features

Clinical Scenario: Suzie

Page 31: Session Three: Genetic Testing Process

What are your initial counseling messages?

Step 1: Communicate goals of microarray testing

Page 32: Session Three: Genetic Testing Process

Keep initial messages simple

A genetic test

because… We’ll use it to…

Page 33: Session Three: Genetic Testing Process

Step 2: Check understanding and assess family expectations

What might Suzie’s family be expecting from results? How would you find out?

Page 34: Session Three: Genetic Testing Process

Families want explanations and guidance

Did I cause it?

What will the future hold?

Page 35: Session Three: Genetic Testing Process

Step 3: Set realistic expectations

What additional information does the family need to be prepared for the various possible outcomes?

Page 36: Session Three: Genetic Testing Process

Reinforce limitations and risks; and discuss the process

Uncertainty is possible…

You’ll get results in…

Unexpected results are possible….

We might need more

tests.

Genes are…

Page 37: Session Three: Genetic Testing Process

Did you adequately prepare the family for this outcome?

Patient Name: Suzie HubbardTest Performed: SNP Array AnalysisIndication: Developmental Delay

Result:Normal Dosage; Long contiguous regions of homozygosity, see interpretation.

Interpretation:Copy number analysis was within normal limits, but there are extended contiguous regions of allele homozygosity (>10Mb) observed in multiple chromosomes that suggests limited outbreeding (possible consanguinity). Recommendations: Consanguinity increases the chance for rare autosomal recessive disorders. Clinical correlation and genetic counseling are recommended.

Page 38: Session Three: Genetic Testing Process

Prepare the family for unexpected results, especially when family information is lacking

Page 39: Session Three: Genetic Testing Process

Summary: Steps to Pre-test Communication

• Step 1: Outline goals

• Step 2: Assess family motivations and aims

• Step 3: Set expectations

Page 40: Session Three: Genetic Testing Process

Consider referral or consult for pre-test counseling

When to consult/refer:

•Lack of time •Low-literacy•Emotional responses•Family undecided

•Data is weak with unclear benefits

Page 41: Session Three: Genetic Testing Process

Order Testing Appropriately

Page 42: Session Three: Genetic Testing Process

What is your experience with ordering genetic tests?

Page 43: Session Three: Genetic Testing Process

Genetic Testing Logistics

Finding a lab

Cost and insurance

Prepare the sample and forms

Reporting practices

Page 44: Session Three: Genetic Testing Process

Finding a Lab

Referral Lab

http://www.ncbi.nlm.nih.gov/gtr

Genetics Specialist

Page 45: Session Three: Genetic Testing Process

Some labs verify

insurance

Genetic testing is medically necessaryDr. Susan Smith

Insurance and Cost

Page 46: Session Three: Genetic Testing Process

Preparing the sample and forms

Genetic Testing Requisition

Clinical History_____________

Family History_____________

Page 47: Session Three: Genetic Testing Process

Reporting Practices Vary

Page 48: Session Three: Genetic Testing Process

Genetic testing can get complicated

Page 49: Session Three: Genetic Testing Process

Summary: Genetic Testing Process

• Use data to assess limitations, benefits and risks

• Anticipate potential results and how you will use them

• Set family expectations

• Expect a higher maintenance ordering process

Page 50: Session Three: Genetic Testing Process

Next steps

• Refer or consult with genetics

• Interpret results in the clinical context• Communicate with families about the

results• Develop a management plan based on

the genetic data

To be discussed in workshop 4

Page 51: Session Three: Genetic Testing Process

Homework/Practice

•Practice assessing limitations, benefits and risks and composing pre-test counseling messages for

– Ataxia telangiectasia

•Use the informed consent checklist and talking points with at least one patient before the next workshop. Be prepared to share your experiences with the group.

www.nchpeg.org/neuro

Page 52: Session Three: Genetic Testing Process

Thank you!

[facilitator contact information]